Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mean BP from initial visit to four years

Published byMorgan Julius Hall Modified over 5 years ago

Similar presentations

Presentation on theme: "Mean BP from initial visit to four years"— Presentation transcript:

1 Mean BP from initial visit to four years
Time Systolic BP + SD (mm Hg) Diastolic BP + SD (mm Hg) Initial visit (n=340) 151+27 80+13 4 y (n=70) 135+18 75+11 Thanamayooran S et al. Nephrol Dial Transplant 2005; 20:

2 Number, type of BP medications from baseline to four years
Time point Medications, n ACE inhibitor or ARB (%) Diuretic (%) Beta blocker (%) Calcium-channel blocker (%) Initial visit 2.20 43 49 38 41 2 y 2.41 65 54 4 y 2.63 64 57 58 Thanamayooran S et al. Nephrol Dial Transplant 2005; 20:

Download ppt "Mean BP from initial visit to four years"

Similar presentations

JNC 8 Guidelines….

JNC 8 Guidelines….
For A Healthy Heart: Blood Pressure Management Presented by: Daniel Schimmel, MD, MS Assistant Professor of Medicine, Cardiology Bluhm Cardiovascular Institute.

For A Healthy Heart: Blood Pressure Management Presented by: Daniel Schimmel, MD, MS Assistant Professor of Medicine, Cardiology Bluhm Cardiovascular Institute.
NHANES III Prevalence of Hypertension* According to BMI

NHANES III Prevalence of Hypertension* According to BMI
HYPERTENSION in ADPKD Sabine Karam M.D.. Introduction  ADPKD is the most common life-threatening single-gene disease  It affects over 12 million people.

HYPERTENSION in ADPKD Sabine Karam M.D.. Introduction  ADPKD is the most common life-threatening single-gene disease  It affects over 12 million people.
Nursing 210 Advanced Cardiac UNIT 2 Laurie Brown RN, MSN, MPA-HA, CCRN.

Nursing 210 Advanced Cardiac UNIT 2 Laurie Brown RN, MSN, MPA-HA, CCRN.
BLOOD PRESSURE 140 90 Systolic Diastolic.

BLOOD PRESSURE Systolic Diastolic.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.

Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Hypertension A Case Study Jennifer Kitchen July 19, 2013.

Hypertension A Case Study Jennifer Kitchen July 19, 2013.
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.

Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
TOMHS 8.3% 6.8% 18.3% 2.8% 6.6% 6.8%. Treatment of Mild Hypertension Study (TOMHS) Eligibility Visits 902 men/women Age 45-69 years DBP 90-99 mm Hg Free.

TOMHS 8.3% 6.8% 18.3% 2.8% 6.6% 6.8%. Treatment of Mild Hypertension Study (TOMHS) Eligibility Visits 902 men/women Age years DBP mm Hg Free.
Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.

Combination Therapy for Hypertension Summary and Comment by Harlan M. Krumholz, MD, SM Published in Journal Watch Cardiology December 3, 2008Journal Watch.
1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.

1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.
Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.

Improving Hypertension Quality Measurement Using Electronic Health Records S Persell, AN Kho, JA Thompson, DW Baker Feinberg School of Medicine Northwestern.
IS AGE AN INDEPENDENT PREDICTOR OF ADVERSE DRUG EVENTS TO LOOP DIURETICS? UMDNJ - SOM Wunhuey Cheng D.O. Mentored by Anita Chopra M.D. Sherry Pomerantz.

IS AGE AN INDEPENDENT PREDICTOR OF ADVERSE DRUG EVENTS TO LOOP DIURETICS? UMDNJ - SOM Wunhuey Cheng D.O. Mentored by Anita Chopra M.D. Sherry Pomerantz.
Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.

Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.
UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,

UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,
UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)

UK Renal Registry 9 th Annual Report 2006 Fig 10.1 Systolic BP mm Hg (pre-HD)
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.

UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
VBWG PROactive: Study design Dormandy JA et al. Lancet. 2005;366:1279-89. Charbonnel B et al. Diabetes Care. 2004;27:1647-53. Objective: Assess the effects.

VBWG PROactive: Study design Dormandy JA et al. Lancet. 2005;366: Charbonnel B et al. Diabetes Care. 2004;27: Objective: Assess the effects.

Similar presentations

Ads by Google